Livzon Pharmaceutical Group Inc.
SZSE:000513.SZ
32.51 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1992 | 1991 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 12,278.523 | 12,629.579 | 12,063.863 | 10,520.41 | 9,384.696 | 8,860.656 | 8,530.969 | 7,651.775 | 6,620.517 | 5,544.234 | 4,618.68 | 3,943.525 | 3,162.915 | 2,726.719 | 2,595.847 | 2,058.641 | 1,748.108 | 1,510.051 | 1,626.146 | 1,554.788 | 1,811.914 | 1,601.206 | 1,395.792 | 1,178.553 | 1,133.82 | 899.045 | 822.213 | 721.128 | 682.735 | 600.07 | 699.718 | 695.919 |
Cost of Revenue
| 4,921.927 | 4,461.283 | 4,253.087 | 3,673.711 | 3,391.728 | 3,359.655 | 3,083.081 | 2,747.788 | 2,575.331 | 2,142.911 | 1,694.615 | 1,569.688 | 1,397.937 | 1,286.485 | 1,231.986 | 1,116.318 | 973.621 | 806.016 | 906.231 | 791.508 | 914.621 | 894.467 | 741.367 | 634.763 | 622.816 | 580.295 | 526.104 | 475.573 | 466.509 | 423.936 | 571.84 | 578.547 |
Gross Profit
| 7,356.596 | 8,168.296 | 7,810.776 | 6,846.699 | 5,992.968 | 5,501.001 | 5,447.888 | 4,903.987 | 4,045.186 | 3,401.323 | 2,924.065 | 2,373.837 | 1,764.978 | 1,440.234 | 1,363.861 | 942.323 | 774.488 | 704.035 | 719.915 | 763.279 | 897.293 | 706.739 | 654.425 | 543.791 | 511.004 | 318.75 | 296.109 | 245.555 | 216.226 | 176.134 | 127.878 | 117.372 |
Gross Profit Ratio
| 0.599 | 0.647 | 0.647 | 0.651 | 0.639 | 0.621 | 0.639 | 0.641 | 0.611 | 0.613 | 0.633 | 0.602 | 0.558 | 0.528 | 0.525 | 0.458 | 0.443 | 0.466 | 0.443 | 0.491 | 0.495 | 0.441 | 0.469 | 0.461 | 0.451 | 0.355 | 0.36 | 0.341 | 0.317 | 0.294 | 0.183 | 0.169 |
Reseach & Development Expenses
| 973.189 | 1,426.523 | 1,145.702 | 884.095 | 732.892 | 548.973 | 427.152 | 291.119 | 222.031 | 189.5 | 146.98 | 124.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 654.274 | 656.857 | 241.85 | 253.523 | 261.466 | 264.772 | 260.385 | 201.224 | 184.966 | 124.629 | 142.719 | 351.031 | 297.63 | 265.89 | 236.727 | 197.767 | 194.614 | 230.855 | 238.241 | 213.292 | 235.114 | 196.794 | 172.191 | 149.276 | 189.599 | 82.766 | 69.651 | 41.637 | 22.006 | 25.203 | 13.222 | 9.893 |
Selling & Marketing Expenses
| 3,598.153 | 3,887.392 | 3,883.875 | 3,075.869 | 3,093.22 | 3,267.28 | 3,265.17 | 3,070.371 | 2,541.675 | 2,208.219 | 1,810.747 | 1,441.654 | 970.891 | 648.046 | 546.253 | 377.277 | 264.866 | 312.118 | 345.651 | 417.779 | 515.908 | 372.506 | 371.299 | 326.855 | 321.165 | 222.9 | 176.566 | 139.879 | 117.214 | 59.967 | 31.854 | 24.125 |
SG&A
| 4,170.545 | 4,544.25 | 4,125.725 | 3,329.391 | 3,354.686 | 3,532.052 | 3,525.555 | 3,271.595 | 2,726.641 | 2,332.848 | 1,953.467 | 1,792.685 | 1,268.521 | 913.936 | 782.98 | 575.044 | 459.481 | 542.973 | 583.892 | 631.071 | 751.022 | 569.3 | 543.489 | 476.131 | 510.765 | 305.666 | 246.217 | 181.515 | 139.22 | 85.17 | 45.077 | 34.018 |
Other Expenses
| -291.022 | -36.88 | 351.717 | 318.208 | 320.443 | 142.433 | 68.634 | 130.173 | 121.131 | 68.871 | 38.563 | 42.642 | 33.568 | 18.087 | 7.442 | 7.948 | 6.949 | -28.571 | 3.112 | 2.657 | 4.608 | 13.142 | 7.535 | 3.441 | 20.693 | 55.959 | 33.015 | 29.426 | 16.218 | 9.445 | 1.411 | -0.571 |
Operating Expenses
| 5,434.755 | 5,933.892 | 5,623.144 | 4,531.694 | 4,408.02 | 4,395.985 | 4,236.207 | 3,915.327 | 3,228.986 | 2,741.934 | 2,306.563 | 1,847.231 | 1,309.252 | 922.794 | 788.709 | 579.509 | 463.546 | 546.779 | 588.01 | 633.158 | 755.701 | 572.188 | 546.699 | 477.449 | 511.402 | 306.055 | 246.319 | 181.515 | 139.22 | 85.288 | 52.297 | 41.274 |
Operating Income
| 1,921.841 | 2,350.556 | 2,266.99 | 2,500.449 | 1,729.853 | 1,274.496 | 5,657.808 | 876.48 | 692.799 | 584.509 | 590.557 | 518.753 | 429.745 | 516.415 | 583.278 | 99.604 | 613.756 | 218.41 | 131.736 | 157.553 | 158.836 | 113.652 | 107.867 | 35.319 | -2.384 | 9.004 | 37.589 | 67.533 | 73.557 | 106.305 | 61.076 | 59.966 |
Operating Income Ratio
| 0.157 | 0.186 | 0.188 | 0.238 | 0.184 | 0.144 | 0.663 | 0.115 | 0.105 | 0.105 | 0.128 | 0.132 | 0.136 | 0.189 | 0.225 | 0.048 | 0.351 | 0.145 | 0.081 | 0.101 | 0.088 | 0.071 | 0.077 | 0.03 | -0.002 | 0.01 | 0.046 | 0.094 | 0.108 | 0.177 | 0.087 | 0.086 |
Total Other Income Expenses Net
| 402.365 | -20.005 | -21.301 | -11.013 | -2.311 | 311.658 | 4,513.242 | 16.401 | -8.279 | -7.364 | 11.438 | 33.706 | 7.425 | 16.227 | 14.267 | -257.16 | 309.037 | 22.363 | -2.578 | 19.048 | 10.366 | -38.203 | -19.353 | -34.589 | 15.999 | 48.317 | 19.83 | 32.868 | 10.721 | 19.828 | -13.578 | -16.702 |
Income Before Tax
| 2,324.206 | 2,330.551 | 2,245.689 | 2,489.436 | 1,727.542 | 1,416.674 | 5,724.923 | 1,005.061 | 807.921 | 652.025 | 628.94 | 560.313 | 463.151 | 533.667 | 589.418 | 105.654 | 619.979 | 184.729 | 132.087 | 154.69 | 157.701 | 111.571 | 101.888 | 35.256 | 16.955 | 62.988 | 70.112 | 96.933 | 88.751 | 113.212 | 62.245 | 59.395 |
Income Before Tax Ratio
| 0.189 | 0.185 | 0.186 | 0.237 | 0.184 | 0.16 | 0.671 | 0.131 | 0.122 | 0.118 | 0.136 | 0.142 | 0.146 | 0.196 | 0.227 | 0.051 | 0.355 | 0.122 | 0.081 | 0.099 | 0.087 | 0.07 | 0.073 | 0.03 | 0.015 | 0.07 | 0.085 | 0.134 | 0.13 | 0.189 | 0.089 | 0.085 |
Income Tax Expense
| 485.066 | 375.01 | 293.588 | 358.109 | 265.965 | 234.96 | 1,237.22 | 175.146 | 148.358 | 98.403 | 104.954 | 85.09 | 75.353 | 81.177 | 75.624 | 32.747 | 96.598 | 35.403 | 15.815 | 19.945 | 36.234 | 25.255 | 27.175 | 9.352 | 7.919 | 15.944 | 15.539 | 10.258 | 7.657 | 10.293 | 3.004 | 1.613 |
Net Income
| 1,953.651 | 1,909.408 | 1,775.683 | 1,714.91 | 1,302.875 | 1,082.175 | 4,428.685 | 784.354 | 622.641 | 515.978 | 487.502 | 441.672 | 359.37 | 418.181 | 481.578 | 52.073 | 508.451 | 139.15 | 107.892 | 124.058 | 92.201 | 61.943 | 50.392 | 10.376 | 1.647 | 40.833 | 43.196 | 81.439 | 80.153 | 101.108 | 59.241 | 57.782 |
Net Income Ratio
| 0.159 | 0.151 | 0.147 | 0.163 | 0.139 | 0.122 | 0.519 | 0.103 | 0.094 | 0.093 | 0.106 | 0.112 | 0.114 | 0.153 | 0.186 | 0.025 | 0.291 | 0.092 | 0.066 | 0.08 | 0.051 | 0.039 | 0.036 | 0.009 | 0.001 | 0.045 | 0.053 | 0.113 | 0.117 | 0.168 | 0.085 | 0.083 |
EPS
| 2.1 | 2.04 | 1.9 | 1.83 | 1.39 | 1.16 | 4.78 | 0.9 | 0.74 | 0.61 | 0.58 | 0.52 | 0.43 | 0.49 | 0.56 | 0.06 | 0.58 | 0.18 | 0.15 | 0.18 | 0.13 | 0.09 | 0.071 | 0.014 | 0.002 | 0.004 | 0.06 | 0.14 | 0.14 | 0.19 | 0.072 | 0.07 |
EPS Diluted
| 2.1 | 2.04 | 1.9 | 1.83 | 1.39 | 1.16 | 4.77 | 0.89 | 0.73 | 0.61 | 0.58 | 0.52 | 0.43 | 0.49 | 0.56 | 0.06 | 0.58 | 0.18 | 0.15 | 0.18 | 0.13 | 0.09 | 0.071 | 0.014 | 0.002 | 0.004 | 0.06 | 0.14 | 0.14 | 0.19 | 0.072 | 0.07 |
EBITDA
| 2,788.219 | 3,277.142 | 2,855.121 | 2,974.885 | 2,175.706 | 1,837.828 | 5,978.646 | 1,503.826 | 1,259.15 | 989.822 | 853.622 | 759.676 | 671.629 | 666.509 | 649.526 | 576.701 | 676.295 | 323.989 | 247.552 | 241.914 | 251.291 | 204.098 | 192.062 | 118.401 | 41.961 | 44.782 | 49.79 | 64.039 | 77.005 | 90.846 | 75.581 | 76.098 |
EBITDA Ratio
| 0.227 | 0.259 | 0.237 | 0.283 | 0.232 | 0.207 | 0.701 | 0.197 | 0.19 | 0.179 | 0.185 | 0.193 | 0.212 | 0.244 | 0.25 | 0.28 | 0.387 | 0.215 | 0.152 | 0.156 | 0.139 | 0.127 | 0.138 | 0.1 | 0.037 | 0.05 | 0.061 | 0.089 | 0.113 | 0.151 | 0.108 | 0.109 |